- Home
- NBY vs IPXX Comparison
NBY vs IPXX Comparison
Compare NBY & IPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- IPXX
- Stock Information
- Founded
- NBY 2000
- IPXX 2023
- Country
- NBY United States
- IPXX United States
- Employees
- NBY N/A
- IPXX N/A
- Industry
- NBY
- IPXX Blank Checks
- Sector
- NBY
- IPXX Finance
- Exchange
- NBY Nasdaq
- IPXX Nasdaq
- Market Cap
- NBY 3.5M
- IPXX N/A
- IPO Year
- NBY 2007
- IPXX 2023
- Fundamental
- Price
- NBY $0.63
- IPXX $10.76
- Analyst Decision
- NBY
- IPXX
- Analyst Count
- NBY 0
- IPXX 0
- Target Price
- NBY N/A
- IPXX N/A
- AVG Volume (30 Days)
- NBY 7.7M
- IPXX 91.4K
- Earning Date
- NBY 11-07-2024
- IPXX 01-01-0001
- Dividend Yield
- NBY N/A
- IPXX N/A
- EPS Growth
- NBY N/A
- IPXX N/A
- EPS
- NBY N/A
- IPXX 0.40
- Revenue
- NBY $13,884,000.00
- IPXX N/A
- Revenue This Year
- NBY N/A
- IPXX N/A
- Revenue Next Year
- NBY $26.04
- IPXX N/A
- P/E Ratio
- NBY N/A
- IPXX $27.08
- Revenue Growth
- NBY 4.06
- IPXX N/A
- 52 Week Low
- NBY $0.07
- IPXX $10.21
- 52 Week High
- NBY $6.30
- IPXX $11.00
- Technical
- Relative Strength Index (RSI)
- NBY 44.88
- IPXX 58.51
- Support Level
- NBY $0.64
- IPXX $10.76
- Resistance Level
- NBY $0.70
- IPXX $10.78
- Average True Range (ATR)
- NBY 0.05
- IPXX 0.02
- MACD
- NBY -0.00
- IPXX -0.00
- Stochastic Oscillator
- NBY 0.00
- IPXX 62.50
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.